However, resistance to VEGF/VEGFR‐targeting drugs has been reported, which may result from hypoxia‐induced signaling and suppression of antitumor immunity, as suggested by analyses of immune cell populations, hypoxic conditions, and GM‐CSF‐regulated MDSC function in preclinical murine tumor models and clinical samples.92 The gene discussed is CSF2; the disease is neoplasm.